fluconazole and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

fluconazole has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, S; Hu, W; Ishibashi, H; Maruyama, N; Ninomiya, K; Oshima, H; Yamaguchi, H1

Other Studies

1 other study(ies) available for fluconazole and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid.
    Medical mycology, 2007, Volume: 45, Issue:2

    Topics: Administration, Inhalation; Animals; Antifungal Agents; Beclomethasone; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Disease Models, Animal; Female; Fluconazole; Histocytochemistry; Immunosuppressive Agents; Mice; Mice, Inbred ICR; Pharynx

2007